Leonard L Mazur's Net Worth
-$13.4 Million
Who is Leonard L Mazur?
Leonard L Mazur does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Tharimmune, Inc., Citius Pharmaceuticals, Inc., PHOTOMEDEX INC, and CITIUS ONCOLOGY, INC..
SEC CIK
Leonard L Mazur's CIK is 0001463414
Past Insider Trading and Trends
NaN was Leonard L Mazur's most active year for acquiring shares with 18 total transactions. Leonard L Mazur's most active month to acquire stocks was the month of Invalid Date. 2022 was Leonard L Mazur's most active year for disposing of shares, totalling 1 transactions. Leonard L Mazur's most active month to dispose stocks was the month of December. NaN saw Leonard L Mazur paying a total of $9,558,346.03 for 24,115,680 shares, this is the most they've acquired in one year. In NaN Leonard L Mazur cashed out on 1,547,067 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Tharimmune, Inc. (THAR) Snapshot price: $2.97
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 21
| |||
Form 4
|
∞
| 123.73K |
$3.36 | $415,945.60 | 123.73K |
Jan 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Citius Pharmaceuticals, Inc. (CTXR) Snapshot price: $0.54
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 10
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 8
| |||
Form 4
| +27.86% | 2.23M |
$0.90 | $2,000,279.97 | 10.26M |
Sep 27
| |||
Form 4
| +16.99% | 1.17M |
$1.55 | $1,799,999.16 | 8.02M |
Apr 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 4
| |||
Form 4
| +84.37% | 3.14M |
$1.28 | $4,000,000.12 | 6.86M |
Aug 13
| |||
Form 4
| +4.72% | 167.5K |
$2.99 | $499,999.44 | 3.72M |
Mar 29
| |||
Form 4
| +6.38% | 213.11K |
$4.69 | $999,467.14 | 3.55M |
Dec 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +0.33% | 11K |
$2.68 | $29,480.00 | 3.34M | ||||
Form 4
| +144.93% | 1.97M |
$3.31 | $6,518,712.03 | 3.33M | ||||
Form 4
| +368.63% | 20.12M |
$0.60 | $3,000,000.00 | 25.57M | ||||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PHOTOMEDEX INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +5.99% | 426 |
$11.75 | $5,005.50 | 7.53K |
Jun 30
| |||
Form 4
| +10.56% | 679 |
$7.37 | $5,004.23 | 7.11K |
May 17
| |||
Form 4
| +18.42% | 1K |
$5.95 | $5,950.00 | 6.43K |
Jan 3
| |||
Form 4
|
∞
| 5.43K |
$5.75 | $31,216.75 | 5.43K |
Dec 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CITIUS ONCOLOGY, INC. (CTOR) Snapshot price: $1.66
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Aug 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||